- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04905186
Different Domains of Executive Function Dual Task Walking on Brain Activation and Gait Performance in Healthy Adults
12. juni 2022 oppdatert av: National Taiwan University Hospital
The Effects of Different Domains of Executive Function Dual Task Walking on Brain Activation and Gait Performance in Healthy Adults
The aim of this study is to investigate the effects of different domains of executive function (EF) during dual task walking condition on brain activation and gait performance in healthy adults.
There are two experiments will be conducted in this study.
Experiment 1 is a pilot study to determine the same level of difficulty in 3 EF domains, including inhibition, working memory and cognitive flexibility.
Experiment 2 is carried out to investigate the effects of 3 different domains of EF which difficulties are controlled on gait performance and brain activation in dual task condition.
10 subjects will perform Stroop test (2s/3s/4s to change question), backward digit spans (3/4/5 digits) and naming test in Experiment 1.
In Experiment 1, the primary outcome is the correct response speed (CRS) while secondary outcome will be the brain activity.
In Experiment 2, 30 subjects will perform the single cognitive task A (SCTA, Stroop test), single cognitive task B (SCTB, backward digit spans), single cognitive task C (SCTC, naming test), single walking task (SWT), dual task A (DTA, walking while performing cognitive task A), dual task B (DTB, walking while performing cognitive task B) and dual task C (DTC, walking while performing cognitive task C).
The CRS, gait performance, brain activity and the dual task costs (DTC) will be recorded in the Experiment 2. Brain activities in prefrontal cortex (PFC), premotor cortex (PMC) and supplementary motor area (SMAs) will be measured by functional near-infrared spectroscopy (fNIRS) during this study.
One-way ANOVA with Tukey post-hoc test will be performed to establish the effect of different type of executive task on CRS or the brain activity.
The differences of gait parameters and brain activity in different condition in the Experiment 2 will be examined by one-way ANOVA with repeated measured.
Furthermore, the Pearson correlation coefficient will be used to examine the correlation of brain activation and executive function performance or gait parameters.
Studieoversikt
Status
Fullført
Forhold
Studietype
Observasjonsmessig
Registrering (Faktiske)
39
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Taipei, Taiwan
- National Taiwan University Hospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
20 år til 30 år (Voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
The population in this study are heathy adults.
Beskrivelse
Inclusion Criteria:
- 20-30 years (Experiment 1 & 2)
- Mini-Mental State Examination (MMSE) score greater than 24 points (Experiment 1 & 2)
- ability to walk 10 meters independently without an assistive device (Experiment 2)
Exclusion Criteria:
- any neurologic, orthopedic or psychological diseases (Experiment 1 & 2)
- color vision deficiency (Experiment 1 & 2)
- had the fall experiences within 6 months before the study (Experiment 2)
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
healthy adults
This is a cross-over study with no intervention.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Experiment 1: Executive function performance- correct response speed (CRS)
Tidsramme: Day 1
|
CRS is the number of correct responses per unit time (correct responses/ second)
|
Day 1
|
|
Experiment 2: Executive function performance- correct response speed (CRS)
Tidsramme: Day 1
|
CRS is the number of correct responses per unit time (correct responses/ second)
|
Day 1
|
|
Experiment 2: walking performance- gait speed
Tidsramme: Day 1
|
The unit is m/s
|
Day 1
|
|
Experiment 2: walking performance- cadence
Tidsramme: Day 1
|
The unit is steps/min
|
Day 1
|
|
Experiment 2: walking performance- stride length
Tidsramme: Day 1
|
The unit is m
|
Day 1
|
|
Experiment 2: dual task performance- dual task costs(DTC) in mobility
Tidsramme: Day 1
|
DTC in mobility = (single task gait speed - dual task gait speed) / single task gait speed x 100%
|
Day 1
|
|
Experiment 2: dual task performance- dual task costs(DTC) in executive function
Tidsramme: Day 1
|
DTC in executive function = (single task correct response speed - dual task correct response speed) / single task correct response speed x 100%
|
Day 1
|
|
Experiment 2: dual task performance- combine mean of dual task costs(DTC)
Tidsramme: Day 1
|
combine mean of DTC = ( DTC in mobility + DTC in executive function) / 2
|
Day 1
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Experiment 1: Brain activation over prefrontal cortex
Tidsramme: Day 1
|
The unit is micro mole (μmol).
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics, including oxygenated-hemoglobin and de-oxygenated hemoglobin.
|
Day 1
|
|
Experiment 1: Brain activities over supplementary motor area
Tidsramme: Day 1
|
The unit is micro mole (μmol).
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics, including oxygenated-hemoglobin and de-oxygenated hemoglobin.
|
Day 1
|
|
Experiment 1: Brain activities over premotor cortex
Tidsramme: Day 1
|
The unit is micro mole (μmol).
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics, including oxygenated-hemoglobin and de-oxygenated hemoglobin.
|
Day 1
|
|
Questionnaire in Chinese version
Tidsramme: Day 1
|
used for the participants to sort the task by the difficulty level based on their own experiences.The participants will be asked to grade the tasks from 1-10 scale.
Scale one is the simplest and 10 is the hardest.
|
Day 1
|
|
Experiment 2: Brain activities over prefrontal cortex
Tidsramme: Day 1
|
The unit is micro mole (μmol).
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics, including oxygenated-hemoglobin and de-oxygenated hemoglobin.
|
Day 1
|
|
Experiment 2: Brain activities over supplementary motor area
Tidsramme: Day 1
|
The unit is micro mole (μmol).
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics, including oxygenated-hemoglobin and de-oxygenated hemoglobin.
|
Day 1
|
|
Experiment 2: Brain activities over premotor cortex
Tidsramme: Day 1
|
The unit is micro mole (μmol).
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics, including oxygenated-hemoglobin and de-oxygenated hemoglobin.
|
Day 1
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. august 2021
Primær fullføring (Faktiske)
23. mai 2022
Studiet fullført (Faktiske)
23. mai 2022
Datoer for studieregistrering
Først innsendt
13. mai 2021
Først innsendt som oppfylte QC-kriteriene
23. mai 2021
Først lagt ut (Faktiske)
27. mai 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
14. juni 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
12. juni 2022
Sist bekreftet
1. juni 2022
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 202103125RINC
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .